XERS
Xeris Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.58
−0.12%Margins
Gross margin
83.3%
EBITDA margin
4.9%
EBIT margin
10.9%
Net margin
-5.1%
FCF margin
16.5%
176.3%
Return on equity
-4.2%
Return on assets
13.1%
Return on invested capital
0.83x
Asset turnover
$56.6M
Cash from operations
$0.67
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026